Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Approaches to Estimation of Anesthesia Agent and Gas Consumption: A Single-Center Retrospective Analysis.

Anesthesia and analgesia·2026
Same author

Use of a Resonance OverShoot Eliminator for correction of an underdamped arterial waveform.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2026
Same author

Feasibility Pilot Trial for the Trajectories of Recovery after Intravenous Propofol versus Inhaled Volatile Anesthesia (THRIVE) Pragmatic Randomized Clinical Trial.

Anesthesiology·2026
Same author

The effect of hospital-level fine particulate matter exposure on surgical complications.

Anaesthesia·2026
Same author

Patient-, Clinician-, and Institution-level Variation in Intraoperative Antihypertensive Use: A Multicenter Observational Analysis.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Disparities in Antiemetic Prophylaxis Care Processes Predicted by Patient Neighborhood: Retrospective Cohort and Geospatial Analysis.

JMIR public health and surveillance·2026

Related Experiment Video

Updated: May 27, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

In silico modelling of physiologic systems.

Richard B Colquitt1, Douglas A Colquhoun, Robert H Thiele

  • 1Department of Anesthesiology, University of Virginia Health System, Charlottesville, VA 22908, USA.

Best Practice & Research. Clinical Anaesthesiology
|November 22, 2011
PubMed
Summary

In silico modeling uses computer simulations to study physiological processes, offering advantages over traditional experiments. This approach provides valuable insights into complex health and disease conditions, particularly in cardio-respiratory research.

More Related Videos

Finite Element Modelling of a Cellular Electric Microenvironment
08:23

Finite Element Modelling of a Cellular Electric Microenvironment

Published on: May 18, 2021

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Experiment Videos

Last Updated: May 27, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Finite Element Modelling of a Cellular Electric Microenvironment
08:23

Finite Element Modelling of a Cellular Electric Microenvironment

Published on: May 18, 2021

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Area of Science:

  • Computational Biology
  • Physiological Modeling
  • Pharmacokinetics

Background:

  • In silico modeling is an extension of in vitro experiments, driven by increased computing power.
  • It combines benefits of in vivo and in vitro methods while avoiding ethical and control limitations.
  • Unlike isolated in vitro studies, in silico models integrate numerous parameters for whole-organism relevance.

Purpose of the Study:

  • To review the application of in silico modeling in cardio-respiratory research.
  • To illustrate the complexity and assumptions inherent in these models.
  • To introduce this growing research strategy.

Main Methods:

  • Development of computer models for pharmacologic or physiologic processes.
  • Application of complex in silico models to pathophysiological problems.
  • Review of examples in cardio-respiratory health and disease.

Main Results:

  • In silico models provide insights unobtainable through traditional clinical research.
  • Applications span physiology, congenital heart surgery, anesthesia, ventilation, and bypass devices.
  • Model utility depends on framework validity and assumptions, with some validated by in vivo studies.

Conclusions:

  • In silico modeling is a powerful, versatile research strategy with significant applications in cardio-respiratory medicine.
  • Understanding model assumptions and validity is crucial for accurate interpretation.
  • This approach is increasingly important and will likely see continued growth.